^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners

    COMPANY:
    Aventa Genomics

    i
    Other names: Aventa Genomics
    Related tests:
    Evidence

    News

    15d
    Aventa Genomics receives favorable pricing determination from centers for medicare and medicaid services (Businesswire)
    "Aventa™ Genomics...today announced that it has received a favorable final pricing determination for the 2025 Centers for Medicare and Medicaid Services (CMS) Clinical Laboratory Fee Schedule (CLFS). The pricing determination is for the Aventa FusionPlus test, a next-generation sequencing test that detects gene fusions, translocations, and rearrangements in solid cancers from formalin-fixed, paraffin-embedded (FFPE) tumor tissue."
    Pricing • Clinical
    |
    Aventa FusionPlus Test
    1year
    Aventa Genomics Announces Launch of Aventa FusionPlus, the First 3D Genomics Clinical Test for Patients with Solid Cancers (Businesswire)
    "Aventa™ Genomics, LLC...announced the launch of Aventa FusionPlus, a next-generation sequencing (NGS) test for the detection of gene fusions, translocations, and rearrangements across 361 genes from formalin-fixed, paraffin embedded (FFPE) tumor tissue. Aventa’s testing service is performed in its CLIA-certified laboratory in Orlando, Florida."
    Launch
    |
    Aventa FusionPlus Test